<!doctype html>
<html lang="en">
  <head>
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <title>Is Vertex Pharmaceuticals Stock Underperforming the S&amp;P 500?</title>
    <meta name="description" content="Moreover, its adjusted EPS of $4.52 surpassed the Street’s estimates by 6.6%.; 4, Vertex Pharmaceuticals released its Q2 results, and its shares plummeted 20.6%.; Longer term, VRTX has plunged 1.6% on a YTD basis, lagging behind $SPX’s 10.2% rise." />
    <link rel="alternate" type="application/rss+xml" title="Daily Finance Newsletter" href="https://suavir600.github.io/newsletter/feed.xml" />
    <style>
:root{--bg:#0b0f19;--fg:#e8ecf2;--muted:#93a1b1;--card:#121826;--accent:#4f8cff}
*{box-sizing:border-box} body{margin:0;background:var(--bg);color:var(--fg);font:16px/1.55 system-ui,-apple-system,Segoe UI,Roboto,Ubuntu}
a{color:var(--accent);text-decoration:none} a:hover{text-decoration:underline}
.container{max-width:980px;margin:0 auto;padding:20px}
.nav{display:flex;align-items:center;justify-content:space-between;margin-bottom:20px}
.brand{font-weight:700} .muted{color:var(--muted)}
.grid{display:grid;grid-template-columns:repeat(auto-fill,minmax(280px,1fr));gap:16px}
.card{background:var(--card);border-radius:16px;padding:16px;box-shadow:0 6px 20px rgba(0,0,0,.25)}
.card h3{margin:0 0 8px 0;font-size:1.05rem}
.badge{display:inline-block;background:#1c2335;color:#c0cad8;padding:.2rem .5rem;border-radius:999px;font-size:.75rem;margin-right:.4rem}
.btn{display:inline-block;background:var(--accent);color:#fff;padding:.5rem .75rem;border-radius:10px;font-weight:600}
.btn-outline{background:transparent;border:1px solid var(--accent);color:var(--accent)}
.list ul{margin:.5rem 0 0 1.2rem}
.footer{margin-top:36px;color:var(--muted);font-size:.9rem;text-align:center}
hr{border:none;border-top:1px solid #223; margin:16px 0}
</style>
  </head>
  <body>
    <div class="container">
      <div class="nav">
        <div class="brand"><a href="https://suavir600.github.io/newsletter">Daily Finance Newsletter</a></div>
        <div class="muted">5–7 key bullets per story</div>
      </div>
      
<h1>Is Vertex Pharmaceuticals Stock Underperforming the S&amp;P 500?</h1>
<div class="muted">2025-09-08 12:35:30+00:00</div>
<hr />
<div class="list"><ul>
  <li>Moreover, its adjusted EPS of $4.52 surpassed the Street’s estimates by 6.6%.</li><li>4, Vertex Pharmaceuticals released its Q2 results, and its shares plummeted 20.6%.</li><li>Longer term, VRTX has plunged 1.6% on a YTD basis, lagging behind $SPX’s 10.2% rise.</li><li>Shares of REGN have declined 50.2% in the last 52 weeks and 19.5% on a YTD basis.</li><li>Driven by continued momentum, the company’s topline for the quarter surged 12.1% year-over-year to $2.96 billion, exceeding the consensus estimates by 2.6%.</li><li>More News from Barchart - CPI, S&amp;P 500 Additions and Other Key Things to Watch this Week - Analysts Keep Raising Shopify&#x27;s Targets - Make a 3.0% Yield in One-Month SHOP OTM Puts However, the biopharmaceutical titan has f</li><li>8, 2024.</li>
</ul></div>
<div style="margin-top:12px">
  <a class="btn-outline" href="https://finance.yahoo.com/m/59379879-7a6a-342d-9125-5ff3f88c0168/is-vertex-pharmaceuticals.html" target="_blank" rel="noopener">Original</a>
  <a class="btn" href="https://twitter.com/intent/tweet?text=Is+Vertex+Pharmaceuticals+Stock+Underperforming+the+S%26P+500%3F%0A%E2%80%A2+Moreover%2C+its+adjusted+EPS+of+%244.52+surpassed+the+Street%E2%80%99s+estimates+by+6.6%25.%0A%E2%80%A2+4%2C+Vertex+Pharmaceuticals+released+its+Q2+results%2C+and+its+shares+plummeted+20.6%25.%0A%E2%80%A2+Longer+term%2C+VRTX+has+plun%E2%80%A6%0Ahttps%3A%2F%2Fsuavir600.github.io%2Fnewsletter%2Farticles%2Fis-vertex-pharmaceuticals-stock-underperforming-the-s-p-500%2F" target="_blank" rel="noopener">Share on X</a>
</div>

      <div class="footer">© 2025 · Built from digest_5bullets.md</div>
    </div>
  </body>
</html>